Colossal Biosciences

Meta’s Llama drama and how Trump’s tariffs could hit moonshot projects

AI /

Meta dropped three new models over the weekend: Scout, Maverick, and the still-training Behemoth, billed as the next evolution of “open-ish” AI. But instead of excitement, the response was mostly shrugs. Critics called the release underwhelming, saying it lacked the edge expected in today’s breakneck AI race. Meta’s clear attempt to claw back some attention […]

Meta’s Llama drama and how Trump’s tariffs could hit moonshot projects Read More »

Does Colossal Biosciences’ dire wolf creation justify its $10B+ valuation?

Climate /

On Monday, the “de-extinction” startup Colossal Biosciences announced its most ambitious results to date: the dire wolf. These are creatures that have been extinct for more than 12,000 years made famous by the HBO show Game of Thrones. These white, fluffy animals live on a 2,000-acre preserve in a location so secretive that journalists, including

Does Colossal Biosciences’ dire wolf creation justify its $10B+ valuation? Read More »

On a quest to revive the woolly mammoth, Colossal Biosciences has created a woolly mouse

Biotech & Health /

Colossal Biosciences, known for its outlandish goal to resurrect the woolly mammoth by 2028, is claiming steady progress. It’s evidence: Genetically engineering mice to have mammoth-like fur. To engineer the woolly mouse, the company’s scientists found mouse versions of mammoth genes and then used CRISPR to edit mice embryos, Dr. Beth Shapiro, chief science officer

On a quest to revive the woolly mammoth, Colossal Biosciences has created a woolly mouse Read More »

Colossal Biosciences raises $200M at $10.2B valuation to bring back woolly mammoths

Biotech & Health /

Colossal Biosciences, the company that’s famously on a mission to bring back the woolly mammoth and two other extinct species, has raised a $200 million Series C at a $10.2 billion valuation from TWG Global, the investment company of Guggenheim Partners co-founder Mark Walter, and the billionaire Thomas Tull. The funding comes two years after

Colossal Biosciences raises $200M at $10.2B valuation to bring back woolly mammoths Read More »